chronic%20obstructive%20pulmonary%20disease
CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Chronic obstructive pulmonary disease (COPD) is an inflammatory respiratory disease characterized by reversible airflow limitation.

The patient usually have chronic cough, sputum production or dyspnea with or without history of risk factors for the disease.

The chronic airflow limitation is caused by a combination of small airways disease and parenchymal destruction.

It is a preventable & treatable disease.

Patient Education

  • It plays an important role in the following:
  • Increasing patient’s knowledge & understanding of the disease
  • Improving skills in symptom recognition, breathing & physical exercise, medication use including proper technique & environmental modification
    • Important to note that adherence to inhaled medications has been associated with reduced risk of death & hospital admission due to COPD exacerbations
    • Measures must be taken to reduce total personal exposure to tobacco smoke, occupational dusts & chemicals & air pollutants
  • Improving attitude toward nutrition & exercise, smoking cessation, quality of life factors & coping skills (eg relaxation techniques, stress management)
  • Improving patient responses to exacerbations
  • Initiating discussions about end-of-life issues including advance directives

Lifestyle Modification

Smoking Cessation

  • The single most effective & cost effective method to reduce the risk of developing COPD & to stop its progression
    • Counseling may be employed to aid patient
    • Pharmacotherapies to aid smoking cessation eg Nicotine preparations, Bupropion & Nortriptyline may be considered (See Smoking Cessation Disease Management Chart)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 02 Oct 2018
Triple therapy with budesonide, glycopyrrolate, and formoterol in one metered dose inhaler (BGF MDI) appears effective and is well-tolerated in patients with symptomatic moderate-to-severe chronic obstructive pulmonary disease (COPD) irrespective of exacerbation history, the multicentre, phase III KRONOS* trial has shown.
Dr. Fanny Wai-San Ko, Dr. Wing-Ho Yip, 15 Aug 2018
Although a majority of patients can achieve good asthma control with the use of inhaled corticosteroid (ICS) and bronchodilators, some patients’ asthma remain uncontrolled despite the use of these medications.
Stephen Padilla, 14 Jan 2019
Overall, the risk of lung cancer is higher in former and current smokers with higher concentrations of high sensitivity C-reactive protein (hsCRP), according to a study. Additionally, circulating hsCRP is not associated with the risk of lung adenocarcinoma and may reflect a prediagnostic disease state rather than a causal risk for lung cancer.
20 Feb 2018
Dr Michael Lim, consultant of the Division of Paediatric Pulmonary and Sleep in National University Hospital, Singapore, shares his insights with Pearl Toh on diagnosing and managing paediatric asthma in the primary care setting.